Marie Suggitt

50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches

Marie Suggitt, Michael C. Bibby · Clinical Cancer Research · 2005 · 297 citations · Full text

<i>In vitro</i>, <i>in vivo</i>, and <i>in silico</i> analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles

Chee Onn Leong, Marie Suggitt, David J. Swaine et al. · Molecular Cancer Therapeutics · 2004 · 89 citations · Full text

Antitumor Activity, Pharmacotherapy, Cell Cycle +20

SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity

John A. Hartley, Anzu Hamaguchi, Marissa Coffils et al. · Cancer Research · 2010 · 59 citations · Full text

Drug Target, Chemoprevention Strategy, Molecular Biology +16

DNA interstrand cross-linking and in vivo antitumor activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057

John A. Hartley, Anzu Hamaguchi, Marie Suggitt et al. · Investigational New Drugs · 2011 · 35 citations

Dna Interstrand Cross-linking, Medicinal Chemistry, Nucleic Acid Chemistry +10

Fluorescent 7-diethylaminocoumarin pyrrolobenzodiazepine conjugates: Synthesis, DNA interaction, cytotoxicity and differential cellular localization

Geoffrey Wells, Marie Suggitt, Marissa Coffils et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 31 citations

Medicine, Natural Sciences, Molecular Biology +7